Osphos 51 Mg/Ml Solution For Injection 15 Ml for Horses | BIOHOOFMED

Premium Equine Care From BIOHOOFMED

BIOHOOFMED delivers high-quality animal medicine through biohoofmed.com.
The platform supports equine health with trusted veterinary solutions.
Therefore, horse owners rely on consistent quality and service.
Moreover, BIOHOOFMED focuses on performance, comfort, and recovery.

Product Overview: Osphos 51 Mg/Ml Solution For Injection

Osphos 51 Mg/ml Solution for Injection, 15 ml supports bone health.
The formulation targets forelimb lameness linked to navicular issues.
Consequently, adult horses regain comfort and mobility.
This solution suits professional equine management programs.

Why Choose Osphos for Horses

Navicular-related discomfort affects performance and welfare.
Therefore, timely intervention becomes essential.
Osphos addresses bone resorptive processes effectively.
As a result, horses show improved movement and balance.
Moreover, trainers report better training continuity.

Indications for Osphos Injection for Horses

Osphos supports adult horses with distal sesamoid involvement.
It alleviates clinical forelimb lameness symptoms.
Additionally, it targets bone resorption-linked conditions.
Thus, it fits horses requiring structured rehabilitation.

Administration and Dosage Guidance

Administer Osphos through intramuscular injection only.
Never inject the product intravenously.
The recommended dose equals 1.8 mg per kilogram.
The maximum dose reaches 900 mg per horse.
Divide the volume across three injection sites.
Discard any unused contents after administration.
Each vial supports single-use only.

Important Usage Precautions

Avoid use in horses under four years old.
Do not treat horses with renal impairment.
Avoid administration with known hypersensitivity.
Use caution with electrolyte imbalance conditions.
Therefore, veterinary evaluation remains essential before treatment.

Safety Measures for Handlers

Handle Osphos with care during preparation.
Avoid accidental self-injection at all times.
Pregnant women should avoid exposure.
Men should also use protective measures.
Seek medical advice after accidental contact.

Clinical Results and Performance Outcomes

Clinical trials show strong success rates.
Over seventy-four percent of treated horses improved.
Placebo results showed minimal improvement.
Moreover, improvement appeared within two months.
Many horses maintained progress for six months.
These outcomes remained independent of shoeing changes.
Therefore, Osphos offers reliable clinical value.

Observed Side Effects and Management

Some horses showed temporary discomfort post-treatment.
Signs included cramping, pawing, or mild colic.
Most symptoms resolved quickly with hand walking.
Only rare cases required medical intervention.
Therefore, monitoring after injection remains recommended.

Re-Treatment and Long-Term Planning

Reassess horses without initial response.
Re-administer Osphos if symptoms return after months.
Schedule follow-ups based on clinical signs.
Thus, long-term comfort remains manageable.
Veterinary guidance ensures optimal timing.

Why Buy Osphos 51 Mg/Ml From BIOHOOFMED

BIOHOOFMED consistently offers competitive pricing.
Bulk buyers receive attractive discounts.
Ordering remains secure and straightforward.
Packaging stays discreet and professional.
Delivery options include regular and express airmail.
Dispatch occurs within two to three business days.

Supporting Responsible Equine Care

Osphos fits structured rehabilitation strategies.
Comfort supports confidence during movement.
Therefore, horses return to work gradually.
Balanced care improves overall welfare outcomes.

Conclusion

Osphos 51 Mg/ml Solution for Injection, 15 ml supports equine bone health.
It alleviates navicular-related forelimb lameness effectively.
Moreover, it delivers proven clinical improvement.
Therefore, BIOHOOFMED remains a trusted source of equine care.
This solution supports comfort, mobility, and performance.